ESC 365 - SGLT2 inhibition and heart failure: a different way of thinking?

Open Access

SGLT2 inhibition and heart failure: a different way of thinking?

Session: SGLT2 inhibition and heart failure: a different way of thinking? (EBAC Accredited)

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor A. Voors (Groningen, NL) Associate Professor M. Cavender (Chapel Hill, US) Professor R. De Boer (Rotterdam, NL) Professor T. McDonagh (London, GB)

Sponsored by AstraZeneca

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speakers

Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))

79 presentations

1 follower

Associate Professor Matthew Cavender

University of North Carolina Hospitals, Chapel Hill (United States of America)

6 presentations

0 follower

Professor Rudolf De Boer

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

61 presentations

8 followers

Professor Theresa McDonagh

King's College Hospital, London (United Kingdom of Great Britain & Northern Ireland)

60 presentations

35 followers

Access the full session

SGLT2 inhibition and heart failure: a different way of thinking? (EBAC Accredited)

Speakers: Professor A. Voors, Associate Professor M. Cavender, Professor R. De Boer, Professor T. McDonagh

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources